Unlocking Overexpressed Membrane Proteins to Guide Breast Cancer Precision Medicine.
Ontology highlight
ABSTRACT: Breast cancer (BC) is a prevalent form of cancer affecting women worldwide. However, the effectiveness of current BC drugs is limited by issues such as systemic toxicity, drug resistance, and severe side effects. Consequently, there is an urgent need for new therapeutic targets and improved tumor tracking methods. This study aims to address these challenges by proposing a strategy for identifying membrane proteins in tumors that can be targeted for specific BC therapy and diagnosis. The strategy involves the analyses of gene expressions in breast tumor and non-tumor tissues and other healthy tissues by using comprehensive bioinformatics analysis from The Cancer Genome Atlas (TCGA), UALCAN, TNM Plot, and LinkedOmics. By employing this strategy, we identified four transcripts (LRRC15, EFNA3,
SUBMITTER: Mendonca JB
PROVIDER: S-EPMC11011122 | biostudies-literature | 2024 Apr
REPOSITORIES: biostudies-literature
ACCESS DATA